As exemplified in our case (S17), even in the presence of a highly suggestive Sotos syndrome phenotype, this assay could easily rule out the clinical diagnosis without proceeding with more complex targeted analyses directed to explore other genomic events involving NSD1. This evidence concerns the gene NSD1 and Sotos syndrome.